Acute urinary retention

From IDWiki
Revision as of 21:17, 3 July 2020 by Maintenance script (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Etiology

  • Prostate
    • Benign prostatic hypertrophy
  • Medication
    • Sympathomimetic
      • Alpha-adrenergic: ephedrine, phenylephrine, phenylpropanolamine, pseudoephedrine
      • Beta-adrenergic: isoproterenol, metaproterenol, terbutaline
    • Antidepressants: imipramine, nortiptyline, amitriptyline, doxepin, amoxepine, maprotiline
    • Antiarrhythmics: quinidine procainamide, disopyramide
    • Anticholinergics: atropine, scopolamine, clidinium, glycopyrrolate, mepenzolate, oxybutynin, flavoxate, hyoscyamine, belladonna, homatropine, propantheline, dicyclomine
    • Antiparkinsonian medications: trihexyphenidyl, benztropine, amantadine, levodopa, bromocriptine
    • Hormone replacement: progesterone, estrogen, testosterone
    • Antipsychotics: haloperidol, thiothixene, thioridizine, chlorpromazine, fluphenazine, prochlorperazine
    • Antihistamines: diphenhydramine, chlorpheniramine, brompheniramine, cyproheptadine, hydroxyzine
    • Antihypertensives: hydralazine, nifedipine
    • Muscle relaxants: diazepam, baclofen, cyclobenzaprine
    • Miscellaneous: indomethacin, carbamazepine, amphetamines, dopamine, vincristine, morphine and other opiates, anaesthetics

Investigations

  • Bladder scan
  • Abdominal ultrasound to rule out hydronephrosis

Management

  • Foley catheterization
  • Monitor lytes, urine lytes, urine output
  • If post-obstructive diuresis
    • Monitor urine output, replace 75% by volume with half-normal saline
    • Monitor electrolytes